ADIPOPHARMA

AdipoPharma SAS is a French biotech company committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. The company was created to commercialize the work of its founder, Dr. Vincent Marion PhD, MSc, and Biochemist and researcher at INSERM, the French National Institute for Health and Medical Research. Dr Marion's team has spent more than a decade identifying therapeutic targets based on the adipocyte's specific role in the metabolic effects of insulin resistance and diabetes. This work began by the detailed genetic investigation of Alström syndrome, an ultra-rare devastating disease characterized by severe insulin resistance, early-onset type 2 diabetes and associated metabolic dysfunctions... for treatment of insulin resistance, type 2 diabetes and associated comorbidities... By harnessing the power of the Adipocyte AdipoPharma is committed to developing innovative treatment for..

Also known as: AdipoPharma LLC, AdipoPharma SAS

Primary location: Illkirch-graffenstaden France